Financhill
Back

Avenue Therapeutics Stock Predictions

Avenue Therapeutics Stock Forecast

  • Is Avenue Therapeutics Stock Undervalued?
    The current Avenue Therapeutics [ATXI] share price is $2.01. The Score for ATXI is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
  • ATXI is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Avenue Therapeutics Stock Go Up Next Year?

Data Unavailable

Avenue Therapeutics Stock Rating

Data Unavailable

Avenue Therapeutics Stock Price History

Is ATXI stock going to rise?

  • The current trend is relatively stagnant and ATXI is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
avenuetx.com

52-Week Data

52-Week High:
26.47
52-Week Low:
1.60

Prediction Charts

Market Cap:
3.84M
Price in USD:
2.01
Volume:
45.63K
Beta:
-0.25

Technical Analysis

SMA50:
2.23
SMA100:
2.58
SMA200:
5.19
52-Wk Change:
-85.51%

Stock Predictions

  • Is Avenue Therapeutics stock public?
    Yes, Avenue Therapeutics is a publicly traded company.
  • What is the Avenue Therapeutics stock quote today?
    The Avenue Therapeutics stock price is 2.01 USD today.
  • How to buy Avenue Therapeutics stock online?
    You can buy Avenue Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-5 2.24 2.22 2.33 2.20
Nov-6 2.25 2.24 2.33 2.24
Nov-7 2.26 2.29 2.29 2.19
Nov-8 2.36 2.23 2.41 2.18
Nov-11 2.10 2.00 2.15 2.00
Nov-12 2.00 2.04 2.09 1.98
Nov-13 2.08 1.95 2.08 1.95
Nov-14 1.95 1.88 1.99 1.80
Nov-15 1.86 1.93 2.06 1.60
Nov-18 1.89 1.90 1.96 1.89
Nov-19 1.94 1.97 1.97 1.90
Nov-20 2.02 2.01 2.05 1.95
Nov-21 1.95 2.01 2.06 1.95
Nov-22 2.03 2.01 2.10 2.00

Avenue Therapeutics Earnings

Data Unavailable

Avenue Therapeutics Forecast Revenue Growth

Data Unavailable

* Avenue Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.